Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

624 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
Sato K, Niimi Y, Ihara R, Suzuki K, Iwata A, Iwatsubo T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Sato K, et al. Among authors: iwatsubo t. J Alzheimers Dis. 2024;99(3):953-963. doi: 10.3233/JAD-231426. J Alzheimers Dis. 2024. PMID: 38759009
The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions.
Kasuga K, Tsukie T, Kikuchi M, Tokutake T, Washiyama K, Shimizu S, Yoshizawa H, Kuroha Y, Yajima R, Mori H, Arakawa Y, Onda K, Miyashita A, Onodera O, Iwatsubo T, Ikeuchi T; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kasuga K, et al. Among authors: iwatsubo t. Neurobiol Aging. 2023 Jul;127:23-32. doi: 10.1016/j.neurobiolaging.2023.03.007. Epub 2023 Mar 17. Neurobiol Aging. 2023. PMID: 37030016 Free article.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team. Sperling RA, et al. Among authors: iwatsubo t. N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17. N Engl J Med. 2023. PMID: 37458272 Free PMC article. Clinical Trial.
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly.
Niimi Y, Janelidze S, Sato K, Tomita N, Tsukamoto T, Kato T, Yoshiyama K, Kowa H, Iwata A, Ihara R, Suzuki K, Kasuga K, Ikeuchi T, Ishii K, Ito K, Nakamura A, Senda M, Day TA, Burnham SC, Iaccarino L, Pontecorvo MJ, Hansson O, Iwatsubo T. Niimi Y, et al. Among authors: iwatsubo t. Alzheimers Res Ther. 2024 May 23;16(1):115. doi: 10.1186/s13195-024-01469-w. Alzheimers Res Ther. 2024. PMID: 38778353 Free PMC article.
Author Correction: Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's disease.
Poulakis K, Pereira JB, Muehlboeck JS, Wahlund LO, Smedby Ö, Volpe G, Masters CL, Ames D, Niimi Y, Iwatsubo T, Ferreira D, Westman E; Japanese Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle study. Poulakis K, et al. Among authors: iwatsubo t. Nat Commun. 2024 Jul 10;15(1):5784. doi: 10.1038/s41467-024-50044-2. Nat Commun. 2024. PMID: 38987238 Free PMC article. No abstract available.
Correction: Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kikuchi M, et al. Among authors: iwatsubo t. Alzheimers Res Ther. 2024 Jul 10;16(1):158. doi: 10.1186/s13195-024-01514-8. Alzheimers Res Ther. 2024. PMID: 38987831 Free PMC article. No abstract available.
624 results